CN101301411B - Chinese medicinal composition for treating angina pectoris - Google Patents
Chinese medicinal composition for treating angina pectoris Download PDFInfo
- Publication number
- CN101301411B CN101301411B CN2008100169705A CN200810016970A CN101301411B CN 101301411 B CN101301411 B CN 101301411B CN 2008100169705 A CN2008100169705 A CN 2008100169705A CN 200810016970 A CN200810016970 A CN 200810016970A CN 101301411 B CN101301411 B CN 101301411B
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- chinese medicine
- angina pectoris
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a medicine, in particular a traditional Chinese medicine composite for curing coronarism of the coronary heart disease. The traditional Chinese medicine composite for curing coronarism of the coronary heart disease is characterized by comprising the following raw materials by weight portion: 2 to 8 grams of nutgall, 2 to 8 grams of tuckahoe, 2 to 8 grams of Bupleurum, 2 to8 grams of medlar, 2 to 8 grams of Salvia miltiorrhiza, 2 to 8 grams of radix sileris, 5 to 11 grams of Gentiana macrophylla, 5 to 11 grams of grassleaf sweelflag rhizome, 5 to 11 grams of rhizoma ligustici wallichii, 5 to 11 grams of glossy privet fruit, 5 to 11 grams of cyrtomium rhizome, 5 to 11 grams of baikal skullcap root, 5 to 11 grams of ormer, 5 to 11 grams of resina draconis, 5 to 11 grams of mongolian snakegourd root, 5 to 11 grams of earthworm, 5 to 11 grams of safflower and 5 to 11 grams of green jade powder. In a word, the traditional Chinese medicine composite has the advantages of safety, reliability, evident healing effect, small side effects and high cure rate.
Description
(1) technical field
The present invention relates to a kind of medicine, particularly a kind of Chinese medicine composition for the treatment of angina pectoris.
(2) background technology
Angina pectoris (hereinafter to be referred as angina pectoris) refers to because of coronary insufficiency, the caused clinical disease of rapid, the temporary transient hypoxic-ischemic of cardiac muscle.Mainly show as behind the breastbone that breaks out and left front pain, be squeezing property or asphyxiating, can take on left, left arm is until nameless and little finger of toe radiation.Pain continues 1～5 minute, seldom surpasses 10～15 minutes, has a rest or contains with nitroglycerin and can alleviate.Angina pectoris is many because of fatigue, heavy meal, excited bringing out, during outbreak, and patient's pale complexion, the expression anxiety, even can be in a cold sweat.
Nothing is specially controlled the specific drug of angina pectoris at present.
(3) summary of the invention
The present invention is in order to remedy the deficiencies in the prior art, and a kind of Chinese medicine composition of treatment angina pectoris evident in efficacy is provided
The present invention is achieved through the following technical solutions:
A kind of Chinese medicine composition for the treatment of angina pectoris, its special character is: the raw material by following parts by weight is made:
Galla Chinensis 2-8g, Poria 2-8g, Radix Bupleuri 2-8g, Fructus Lycii 2-8g, Radix Salviae Miltiorrhizae 2-8g, Radix Saposhnikoviae 2-8g, Radix Gentianae Macrophyllae 5-11g, Rhizoma Acori Graminei 5-11g, Rhizoma Chuanxiong 5-11g, Fructus Ligustri Lucidi 5-11g, Rhizoma Osmundae 5-11g, Radix Scutellariae 5-11g, Concha Haliotidis 5-11g, Sanguis Draxonis 5-11g, Radix Trichosanthis 5-11g, Pheretima 5-11g, Flos Carthami 5-11g, BIYUSAN 5-11g.
The Chinese medicine composition of treatment angina pectoris of the present invention, described medicine are water decoction, granule or capsule.
Medicine of the present invention can obviously increase dog coronary flow and myocardial flow, reduces coronary resistance, obviously reduces degree of myocardial ischemia.
Below for the observation of curative effect of medicine of the present invention:
(1) case is selected:
In the period of 1999 2006,400 routine cardiacs are taken medicine of the present invention, old myocardial infarction 46 examples wherein, latent coronary heart disease 88 examples, angina pectoris 266 examples, male patient's 245 examples, women patient's 155 examples, 57.25 years old mean age, course of disease 1-11, average 7.5 years.All the patient takes the granule of making by the method for embodiment 1, each 2 grams, and every day 2 times, be 1 month the course of treatment.
(2) evaluation criteria:
The course of treatment standard: produce effects: clinical symptom disappearance, electrocardiogram recovers normal during rest, or roughly normal, other every corresponding improvement; Effectively: clinical symptoms disappears substantially, and the angina pectoris number of times reduces, and the nitroglycerin consumption reduces over half, substantially need not obey nitroglycerin, during rest more than the electrocardiogram S-T section rise 0.05mV, but still fail normal, the T ripple that precordial leads is put shoals, or the T ripple is upright by smooth change; Invalid: basic identical before and after the treatment of clinical symptoms and electrocardiogram after 1 month.
(3) result:
Treat 400 examples altogether, old myocardial infarction 46 examples wherein, produce effects 38 examples, effective 6 examples, invalid 2 examples; Latent coronary heart disease 88 examples, produce effects 64 examples, effective 19 examples, invalid 5 examples; Angina pectoris 266 examples, produce effects 201 examples, effective 51 examples, invalid 4 examples.Total effective rate is 97.25%.Have no adverse reaction during the treatment.
In sum, the present invention has advantage safe and reliable, evident in efficacy, that side effect is little, cure rate is high.
(4) specific embodiment
Embodiment 1:
Get Galla Chinensis 2g, Poria 2g, Radix Bupleuri 2g, Fructus Lycii 2g, Radix Salviae Miltiorrhizae 2g, Radix Saposhnikoviae 2g, Radix Gentianae Macrophyllae 11g, Rhizoma Acori Graminei 11g, Rhizoma Chuanxiong 11g, Fructus Ligustri Lucidi 11g, Rhizoma Osmundae 11g, Radix Scutellariae 11g, Concha Haliotidis 11g, Sanguis Draxonis 11g, Radix Trichosanthis 11g, Pheretima 11g, Flos Carthami 11g, BIYUSAN 11g.
Above medicament mixed decocting concentrates, and makes granule, every day 2-3 time, and each 2 grams, oral.
Embodiment 2:
Get Galla Chinensis 8g, Poria 8g, Radix Bupleuri 8g, Fructus Lycii 8g, Radix Salviae Miltiorrhizae 8g, Radix Saposhnikoviae 8g, Radix Gentianae Macrophyllae 5g, Rhizoma Acori Graminei 5g, Rhizoma Chuanxiong 5g, Fructus Ligustri Lucidi 5g, Rhizoma Osmundae 5g, Radix Scutellariae 5g, Concha Haliotidis 5g, Sanguis Draxonis 5g, Radix Trichosanthis 5g, Pheretima 5g, Flos Carthami 5g, BIYUSAN 5g.Above medicament mixed decocting concentrates, and makes water decoction according to a conventional method, and is every day 2-3 time, oral.
Embodiment 3:
Get Galla Chinensis 6g, Poria 6g, Radix Bupleuri 4g, Fructus Lycii 5g, Radix Salviae Miltiorrhizae 5g, Radix Saposhnikoviae 5g, Radix Gentianae Macrophyllae 8g, Rhizoma Acori Graminei 8g, Rhizoma Chuanxiong 8g, Fructus Ligustri Lucidi 8g, Rhizoma Osmundae 8g, Radix Scutellariae 8g, Concha Haliotidis 8g, Sanguis Draxonis 8g, Radix Trichosanthis 8g, Pheretima 8g, Flos Carthami 8g, BIYUSAN 8g.Above medicament mixed decocting concentrates, and makes capsule according to a conventional method, and is every day 2-3 time, each 2, oral.
Claims (2)
1. Chinese medicine composition for the treatment of angina pectoris, it is characterized in that: the raw material by following parts by weight is made:
Galla Chinensis 2-8g, Poria 2-8g, Radix Bupleuri 2-8g, Fructus Lycii 2-8g, Radix Salviae Miltiorrhizae 2-8g, Radix Saposhnikoviae 2-8g, Radix Gentianae Macrophyllae 5-11g, Rhizoma Acori Graminei 5-11g, Rhizoma Chuanxiong 5-11g, Fructus Ligustri Lucidi 5-11g, Rhizoma Osmundae 5-11g, Radix Scutellariae 5-11g, Concha Haliotidis 5-11g, Sanguis Draxonis 5-11g, Radix Trichosanthis 5-11g, Pheretima 5-11g, Flos Carthami 5-11g, BIYUSAN 5-11g.
2. the Chinese medicine composition of treatment angina pectoris according to claim 1 is characterized in that: described medicine is water decoction, granule or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100169705A CN101301411B (en) | 2008-06-27 | 2008-06-27 | Chinese medicinal composition for treating angina pectoris |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100169705A CN101301411B (en) | 2008-06-27 | 2008-06-27 | Chinese medicinal composition for treating angina pectoris |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101301411A CN101301411A (en) | 2008-11-12 |
| CN101301411B true CN101301411B (en) | 2011-05-11 |
Family
ID=40111628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100169705A Expired - Fee Related CN101301411B (en) | 2008-06-27 | 2008-06-27 | Chinese medicinal composition for treating angina pectoris |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101301411B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105709186A (en) * | 2015-05-20 | 2016-06-29 | 唐均停 | Pharmaceutical composition for treating coronary heart disease and angina |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1075648A (en) * | 1993-01-06 | 1993-09-01 | 张良华 | Have one's ideas straightened out comfortable production method |
-
2008
- 2008-06-27 CN CN2008100169705A patent/CN101301411B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1075648A (en) * | 1993-01-06 | 1993-09-01 | 张良华 | Have one's ideas straightened out comfortable production method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101301411A (en) | 2008-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101347563B (en) | Medicament for treating baldness and white hair and preparation method thereof | |
| CN100382839C (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN103083531A (en) | Drug for treating diabetes | |
| CN101011522B (en) | Chinese traditional medicine for treating cardiopathy | |
| CN101757322B (en) | Vegetable drug compound preparation for treating urarthritis as well as preparation and application thereof | |
| CN100522226C (en) | Composition of Chinese traditional medicine for treating coronary heart disease | |
| CN101301411B (en) | Chinese medicinal composition for treating angina pectoris | |
| CN103330868A (en) | Intestinal tract replenishing liquid for chronic renal failure | |
| CN101024048A (en) | Medicine for treating heart disease | |
| CN101194947B (en) | Chinese medicine for treating angiocardiopathy | |
| CN101057922A (en) | Traditional Chinese medicine preparation for treating vitiligo | |
| CN1792372A (en) | Traditional Chinese medicine prepn. for treating diabetes | |
| CN102552520A (en) | Blood circulation-promoting and pain-stopping medicament for treating chest stuffiness and pains and preparation process and application thereof | |
| CN104645207A (en) | Traditional Chinese medicine composition for treating angina | |
| CN102049005B (en) | Chinese medicinal preparation for treating coronary heart diseases | |
| CN104107242B (en) | A kind of Chinese medicine composition for the treatment of hyperthyroidism and its production and use | |
| CN102284023A (en) | Chinese medicinal composition for treating asthma | |
| CN103006998B (en) | Medicine for treating acute glomerulonephritis (AGN) hypertensive crisis | |
| CN100406054C (en) | Chinese-medicinal preparation for treating hypertension and preventing lesion | |
| CN103028088B (en) | Traditional Chinese medicine composition for treating coronary heart disease and angina | |
| CN107213343A (en) | A kind of canker sore Chinese medicine ointment containing bletilla and preparation method thereof | |
| CN1242198A (en) | Traditional Chinese medicine capsule for treating coronary heart disease | |
| CN100333769C (en) | Chinese herbal granule for treating viral myocarditis and its preparing process | |
| CN103127413A (en) | Pharmaceutical preparation for treating coronary diseases | |
| CN112426505A (en) | Chinese patent medicine for treating perimenopausal cardiac neurosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110511 Termination date: 20120627 |